185 related articles for article (PubMed ID: 9689134)
1. Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B.
Chou TC; Zhang XG; Balog A; Su DS; Meng D; Savin K; Bertino JR; Danishefsky SJ
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9642-7. PubMed ID: 9689134
[TBL] [Abstract][Full Text] [Related]
2. The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice.
Chou TC; O'Connor OA; Tong WP; Guan Y; Zhang ZG; Stachel SJ; Lee C; Danishefsky SJ
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):8113-8. PubMed ID: 11438750
[TBL] [Abstract][Full Text] [Related]
3. Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel.
Chou TC; Zhang XG; Harris CR; Kuduk SD; Balog A; Savin KA; Bertino JR; Danishefsky SJ
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15798-802. PubMed ID: 9861050
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral route.
Chou TC; Dong H; Zhang X; Tong WP; Danishefsky SJ
Cancer Res; 2005 Oct; 65(20):9445-54. PubMed ID: 16230408
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis and antitumor activity of 12,13-desoxyepothilone F: an unexpected solvolysis problem at C15, mediated by remote substitution at C21.
Lee CB; Chou TC; Zhang XG; Wang ZG; Kuduk SD; Chappell MD; Stachel SJ; Danishefsky SJ
J Org Chem; 2000 Oct; 65(20):6525-33. PubMed ID: 11052097
[TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts.
Newman RA; Yang J; Raymond M; Finlay V; Cabral F; Vourloumis D; Stephens LC; Troncoso P; Wu X; Logothetis CJ; Nicolaou KC; Navone NM
Cancer Chemother Pharmacol; 2001 Oct; 48(4):319-26. PubMed ID: 11710633
[TBL] [Abstract][Full Text] [Related]
7. On the interactivity of complex synthesis and tumor pharmacology in the drug discovery process: total synthesis and comparative in vivo evaluations of the 15-aza epothilones.
Stachel SJ; Lee CB; Spassova M; Chappell MD; Bornmann WG; Danishefsky SJ; Chou TC; Guan Y
J Org Chem; 2001 Jun; 66(12):4369-78. PubMed ID: 11397179
[TBL] [Abstract][Full Text] [Related]
8. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
9. Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions.
Verrills NM; Flemming CL; Liu M; Ivery MT; Cobon GS; Norris MD; Haber M; Kavallaris M
Chem Biol; 2003 Jul; 10(7):597-607. PubMed ID: 12890533
[TBL] [Abstract][Full Text] [Related]
10. On the total synthesis and preliminary biological evaluations of 15(R) and 15(S) aza-dEpoB: a Mitsunobu inversion at C15 in pre-epothilone fragments.
Stachel SJ; Chappell MD; Lee CB; Danishefsky SJ; Chou TC; He L; Horwitz SB
Org Lett; 2000 Jun; 2(11):1637-9. PubMed ID: 10841498
[TBL] [Abstract][Full Text] [Related]
11. Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity.
Altmann KH; Wartmann M; O'Reilly T
Biochim Biophys Acta; 2000 May; 1470(3):M79-91. PubMed ID: 10799747
[No Abstract] [Full Text] [Related]
12. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect against human xenograft tumors in nude mice by the third generation microtubule stabilizing epothilones.
Chou TC; Zhang X; Zhong ZY; Li Y; Feng L; Eng S; Myles DR; Johnson R; Wu N; Yin YI; Wilson RM; Danishefsky SJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13157-62. PubMed ID: 18755900
[TBL] [Abstract][Full Text] [Related]
14. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.
Hood KA; West LM; Rouwé B; Northcote PT; Berridge MV; Wakefield SJ; Miller JH
Cancer Res; 2002 Jun; 62(12):3356-60. PubMed ID: 12067973
[TBL] [Abstract][Full Text] [Related]
15. A comparison of signaling activities induced by Taxol and desoxyepothilone B.
Bergstralh DT; Taxman DJ; Chou TC; Danishefsky SJ; Ting JP
J Chemother; 2004 Dec; 16(6):563-76. PubMed ID: 15700849
[TBL] [Abstract][Full Text] [Related]
16. Epothilone B and its analogs - a new family of anticancer agents.
Altmann KH
Mini Rev Med Chem; 2003 Mar; 3(2):149-58. PubMed ID: 12570848
[TBL] [Abstract][Full Text] [Related]
17. En route to a plant scale synthesis of the promising antitumor agent 12,13-desoxyepothilone B.
Chappell MD; Stachel SJ; Lee CB; Danishefsky SJ
Org Lett; 2000 Jun; 2(11):1633-6. PubMed ID: 10841497
[TBL] [Abstract][Full Text] [Related]
18. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)).
Kowalski RJ; Giannakakou P; Hamel E
J Biol Chem; 1997 Jan; 272(4):2534-41. PubMed ID: 8999970
[TBL] [Abstract][Full Text] [Related]
19. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
[TBL] [Abstract][Full Text] [Related]
20. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
